-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| T763698 | 127985-74-4 | 2-[4,7,10-tris(carboxymethyl)-6-[(4-isothiocyanatophenyl)methyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid, 98% 2-[4,7,10-tris(carboxymethyl)-6-[(4-isothiocyanatophenyl)methyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid, 98% |
C24H33N5O8S | |
| A998375 | Anti-158P1D7 Reference Antibody (Agensys patent anti-158P1D7), Anti-158P1D7 Reference Antibody (Agensys patent anti-158P1D7), |
|||
| A998376 | Anti-ABCB5 Reference Antibody (Brigham and Women's patent anti-ABCB5), Anti-ABCB5 Reference Antibody (Brigham and Women's patent anti-ABCB5), |
|||
| A998377 | Anti-ACE2 Antibody (NCOV-7), Anti-ACE2 Antibody (NCOV-7), |
|||
| A998383 | Anti-Adrenomedullin Reference Antibody (enibarcimab), Anti-Adrenomedullin Reference Antibody (enibarcimab), |
|||
| A998384 | Anti-AGER / RAGE Reference Antibody (XT-M4), Anti-AGER / RAGE Reference Antibody (XT-M4), |
|||
| A998385 | Anti-Albumin Reference Antibody (Numab patent anti-HSA), Anti-Albumin Reference Antibody (Numab patent anti-HSA), |
|||
| A998386 | Anti-ALCAM / CD166 Reference Antibody (AT002), Anti-ALCAM / CD166 Reference Antibody (AT002), |
|||
| A998387 | Anti-ALCAM / CD166 Reference Antibody (praluzatamab), Anti-ALCAM / CD166 Reference Antibody (praluzatamab), |
|||
| A998388 | Anti-Alpha-synuclein Reference Antibody (cinpanemab), Anti-Alpha-synuclein Reference Antibody (cinpanemab), |
|||
| A998389 | Anti-Alpha-synuclein Reference Antibody (prasinezumab), Anti-Alpha-synuclein Reference Antibody (prasinezumab), |
|||
| A998390 | Anti-AMHR2 Reference Antibody (murlentamab), Anti-AMHR2 Reference Antibody (murlentamab), |
|||
| A998391 | Anti-Amyloid Alpha Reference Antibody (birtamimab), Anti-Amyloid Alpha Reference Antibody (birtamimab), |
|||
| A998392 | Anti-Amyloid Beta Reference Antibody (aducanumab), Anti-Amyloid Beta Reference Antibody (aducanumab), |
|||
| A998393 | Anti-Amyloid Beta Reference Antibody (Amgen patent anti-beta amyloid), Anti-Amyloid Beta Reference Antibody (Amgen patent anti-beta amyloid), |
|||
| A998394 | Anti-Amyloid Beta Reference Antibody (bapineuzumab), Anti-Amyloid Beta Reference Antibody (bapineuzumab), |
|||
| A998395 | Anti-Amyloid Beta Reference Antibody (CNTO 2125), Anti-Amyloid Beta Reference Antibody (CNTO 2125), |
|||
| A998396 | Anti-Amyloid Beta Reference Antibody (crenezumab), Anti-Amyloid Beta Reference Antibody (crenezumab), |
|||
| A998397 | Anti-Amyloid Beta Reference Antibody (CSIRO anti-amyloid Beta scFv), Anti-Amyloid Beta Reference Antibody (CSIRO anti-amyloid Beta scFv), |
|||
| A998398 | Anti-Amyloid Beta Reference Antibody (DLX212), Anti-Amyloid Beta Reference Antibody (DLX212), |
